CEPHALOSTATIN 12

ID: ALA403143

Max Phase: Preclinical

Molecular Formula: C54H76N2O12

Molecular Weight: 945.20

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Cephalostatin 12
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[C@@H]1[C@]2(O[C@H]3C=C4[C@@H]5CC[C@H]6Cc7nc8c(nc7C[C@]6(C)[C@H]5C[C@@H](O)[C@]4(C)[C@]31O)C[C@@H]1CC[C@H]3C4=C[C@@H]5O[C@]6(O[C@](C)(CO)C[C@H]6O)[C@@H](C)[C@]5(O)[C@@]4(C)[C@H](O)C[C@@H]3[C@@]1(C)C8)O[C@](C)(CO)C[C@H]2O

    Standard InChI:  InChI=1S/C54H76N2O12/c1-25-51(63)43(65-53(25)41(61)21-45(3,23-57)67-53)17-33-29-11-9-27-13-35-37(19-47(27,5)31(29)15-39(59)49(33,51)7)55-36-14-28-10-12-30-32(48(28,6)20-38(36)56-35)16-40(60)50(8)34(30)18-44-52(50,64)26(2)54(66-44)42(62)22-46(4,24-58)68-54/h17-18,25-32,39-44,57-64H,9-16,19-24H2,1-8H3/t25-,26-,27-,28-,29+,30+,31-,32-,39+,40+,41+,42+,43-,44-,45-,46-,47-,48-,49+,50+,51+,52+,53-,54-/m0/s1

    Standard InChI Key:  NVRMDLWDRHEFNO-LGANMPMMSA-N

    Associated Targets(Human)

    Panel (Carcinoma cell lines) 272 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    MCF7 126967 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SF-268 49410 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    NCI-H460 60772 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    DU-145 51482 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    P388 20296 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 945.20Molecular Weight (Monoisotopic): 944.5398AlogP: 3.38#Rotatable Bonds: 2
    Polar Surface Area: 224.54Molecular Species: NEUTRALHBA: 14HBD: 8
    #RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
    CX Acidic pKa: 12.40CX Basic pKa: 1.52CX LogP: 1.60CX LogD: 1.60
    Aromatic Rings: 1Heavy Atoms: 68QED Weighted: 0.20Np Likeness Score: 1.20

    References

    1. Pettit GR, Ichihara Y, Xu J, Boyd MR, Williams MD.  (1994)  Isolation and structure of the symmetrical disteroidal alkaloids cephalostatin 12 and cephalostatin 13,  (12): [10.1016/S0960-894X(01)80522-9]
    2. Moser BR..  (2008)  Review of cytotoxic cephalostatins and ritterazines: isolation and synthesis.,  71  (3): [PMID:18197599] [10.1021/np070536z]
    3. Pettit GR, Moser BR, Mendonça RF, Knight JC, Hogan F..  (2012)  The cephalostatins. 22. synthesis of bis-steroidal pyrazine pyrones (1).,  75  (6): [PMID:22607450] [10.1021/np300069z]
    4. Pettit GR, Xu JP, Chapuis JC, Melody N..  (2015)  The Cephalostatins. 24. Isolation, Structure, and Cancer Cell Growth Inhibition of Cephalostatin 20.,  78  (6): [PMID:26042639] [10.1021/acs.jnatprod.5b00129]

    Source